Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Accept all cookies Reject all non-essential cookies Find out more

INTACT

Trial Status: Complete

INtravenous Iron to Treat Anaemia in CriTical Care Survivors: a feasibility study

The overarching aim is to test whether or not treating anaemia in survivors of intensive care improves quality of life and symptoms such as fatigue in a large multicentre trial. INTACT will be a feasibility, randomised trial with the primary aim of assessing the recruitment and randomisation rates to inform the design of a future large multicentre trial.